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1. Abstract 
 
The Cl- and HCO3- electrochemical gradients across the plasma membrane dictate 
the electrical consequences of GABAA receptor (GABAAR) function and thereby play a 
significant role in neuronal GABA-mediated signalling. In adult pyramidal neurons, 
responses to GABA are maintained hyperpolarizing mainly by the action of K-Cl 
cotransporter isoform 2 (KCC2). KCC2 acts as a Cl- extrusion mechanism responsible for 
setting the intracellular Cl- concentration below the electrochemical equilibrium, a 
necessary condition for hyperpolarizing inhibition mediated by GABAARs. 
Recent evidence suggests that plasmalemmal KCC2 has a very high rate of 
turnover, pointing to a novel role for changes in KCC2 expression in diverse 
manifestations of neuronal plasticity. Some studies indicate that rapid down-regulation of 
KCC2 may be a general early response involved in various kinds of neuronal trauma. 
In this work, whole-cell patch-clamp was used to examine KCC2 function under a 
pharmacologically induced arrest of protein synthesis in living hippocampal brain slices 
from rat. The stability of KCC2 function was quantitatively assessed on the basis of the 
dendritic Cl- extrusion capacity in the presence of protein synthesis inhibitors 
cycloheximide and emetine. The parameter used for assessing extrusion capacity was a 
somato-dendritic Cl- gradient, which was imposed by a somatic Cl- load that resulted in a 
gradient of EGABA (∆EGABA).  
The results of this study show that under general protein synthesis inhibitor-
induced arrest of translation, KCC2 function persists unperturbed for at least 4 hours and 
hence that the cessation of mRNA translation cannot rapidly induce downregulation of 
KCC2-mediated Cl- extrusion. This finding precludes the use of protein synthesis 
inhibitors for rapid modulation of KCC2 function. Indirectly, the results presented here 
imply that the levels of KCC2 under pathophysiological conditions are primarily 
determined by the degradation rate and not by de novo synthesis.   
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2. Introduction 
 
2.1 GABAAR-mediated inhibition 
 
Electrical signaling in excitable cells is generated by dissipating actively 
maintained ionic gradients via the opening of neurotransmitter- and voltage-gated ion 
channels. Consequently, all brain function boils down to and emerges from the action of 
plasmalemmal transport proteins that distribute ions asymmetrically across cell 
membranes.  
GABA (γ-aminobutyric acid) is the main inhibitory neurotransmitter in the adult 
mammalian central nervous system (CNS). It inhibits neuronal firing by activating 
ionotropic type A GABA receptors (GABAARs) primarily permeant to chloride (Cl-) and, 
to a lesser extent, bicarbonate (HCO3-) ions (Kaila and Voipio 1987; Kaila 1994). Fast 
GABAAR-mediated inhibition is defined as a transient decrease in the firing probability 
of the target cell (Farrant and Kaila 2007). It is based on the conductance mediated by 
GABAARs and on the inward-directed transmembrane electrochemical Cl- gradient that 
facilitates net inward Cl- flux upon GABAAR activation. This net Cl- influx manifests as 
the major outward current component, in addition to the usually much smaller inward 
HCO3- efflux-carried component, of the hyperpolarizing post-synaptic GABAAR-
mediated current (IGABA) that transiently brings the resting membrane potential (Em) 
towards the reversal potential of GABAAR-mediated currents (EGABA-A or here simply 
EGABA). Provided an intracellular Cl- concentration ([Cl-]i) of ≈ 20 mM or higher, EGABA 
is roughly equal to ECl, the reversal potential of the current carried by Cl- (Farrant and 
Kaila 2007). The difference between Em and EGABA defines the direction and the driving 
force for net Cl- flux and, thus, whether GABAAR activation will lead to 
hyperpolarization or to depolarization of the membrane potential.  
In the rat hippocampus, fast GABAergic synaptic signaling is depolarizing during 
the early postnatal period, becoming hyperpolarizing only by the second postnatal week 
(Cherubini et al. 1991). In contrast to the inwardly directed electrochemical gradient of 
Cl- in neurons with hyperpolarizing GABAergic responses, an outwardly directed 
gradient, that leads to net Cl- efflux upon GABAAR activation, underlies the depolarizing 
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or even excitatory effect of GABA in the early postnatal life and also possibly under 
certain post-traumatic conditions of the adult brain (Katchman et al. 1994; van den Pol et 
al. 1996; Nabekura et al. 2002).  
Transmembrane Cl- concentration gradients, the prerequisite for GABA-mediated 
voltage signaling, are a product of active transport. The cation-chloride cotransporters 
(CCCs) are membrane proteins that transport Cl- together with the cations sodium (Na+) 
and/or potassium (K+) across biological membranes. CCCs do not directly utilize ATP-
derived energy, and are thus secondary active transporters that harness the energy for Cl- 
transport from the Na-K ATPase-generated chemical potential differences for Na+ and K+ 
(Farrant and Kaila 2007). Many members of the CCC protein family, encoded by the 
genes Slc12a1-9, are expressed in the CNS (Mercado et al. 2004). However, expression 
of one member, the Slc12a5, known as the K-Cl cotransporter isoform 2 (KCC2), is 
exclusively restricted to central neurons (Payne et al. 1996; Uvarov et al. 2005 and 2007). 
KCC2 functions as a Cl- extrusion mechanism and is responsible for the low [Cl-]i that 
underlies the functionally inhibitory effect of GABA (Rivera et al. 1999; Blaesse et al. 
2009).  
 
2.2 KCC2 renders GABA hyperpolarizing in the mature brain 
 
Originally studied in the context of volume regulation, K-Cl cotransport (KCC) 
has emerged as a pivotal factor that controls the transmembrane Cl- electrochemical 
gradient requisite for “classical” hyperpolarizing inhibition mediated by GABAARs and 
glycine receptors in excitable cells (Payne et al. 2003). In the vast majority of rat cortical 
neurons, KCC2 expression and activity increase during postnatal development (Blaesse et 
al. 2009). As net Cl- extrusion is enhanced as a consequence of increased K-Cl 
cotransport, a developmental hyperpolarizing shift occurs in the so far depolarizing 
GABA- and glycine-elicited post-synaptic potentials.  
The unique localization of KCC2 in central neurons (Payne et al. 1996; Uvarov et 
al. 2005, 2007) alone is not sufficient to determine KCC2 as the main Cl- extruder 
rendering GABA hyperpolarizing in the brain. However, the crucial role of KCC2 in 
maintaining hyperpolarizing GABAergic responses has been demonstrated in functional 
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studies manipulating KCC2 expression. As was first demonstrated by Rivera et al. 
(1999), reducing the expression levels of KCC2 protein by antisense oligonucleotides 
leads to loss of fast hyperpolarizing responses to muscimol, a GABAAR-specific agonist, 
in functionally mature hippocampal pyramidal neurons. The significance of KCC2 in 
neuronal function was reinforced by Hübner et al. (2001), who demonstrated that 
knockout mice deficient in KCC2 die immediately after birth and implied that the 
responses to GABA and glycine of their embryonic spinal cord motoneurons are 
characteristically excitatory, in contrast to the strictly hyperpolarizing responses of wild 
type mice. Recently, a novel KCC2 splice variant was characterized (named KCC2a) 
(Uvarov et al. 2007). It differs from the previously characterized KCC2 isoform (now 
termed KCC2b) by 40 amino acids in the N-terminus encoded by an alternatively spliced 
exon. Mice lacking the KCC2b splice variant but not the KCC2a show neuronal 
hyperexcitability and increased susceptibility to epileptic seizures and do not survive 
beyond postnatal day 17 (Woo et al. 2002). Mice lacking both KCC2 splice variants die 
after birth due to respiratory failure, possibly as a result of malfunction of the respiratory 
centre caused by disinhibition (Hübner et al. 2001). 
Immature cortical neurons, devoid of active KCC2, characteristically possess 
outward transmembrane Cl- electrochemical gradients, maintained via net Cl- uptake by 
the Na-K-Cl cotransporter isoform 1 (NKCC1) (Payne et al. 2003). Preventing the 
function of NKCC1 with the diuretic bumetanide does not result in the Cl- extrusion 
efficacy levels observed in neurons with efficient KCC2-mediated K-Cl cotransport 
(Khirug et al. 2010, submitted), which points to that a mere developmental 
downregulation of NKCC1 function is unlikely to result in the low [Cl-]i that underlies 
the functionally inhibitory effect of GABA in mature hippocampal pyramidal neurons. 
Taken together, these studies, which elucidate the importance of KCC2 
expression in maintenance of hyperpolarizing GABAergic responses, have implicated 
KCC2 as the neuronal Cl- extrusion mechanism responsible for setting the [Cl-]i below 
the electrochemical equilibrium, an imperative condition for GABAAR-mediated 
hyperpolarizing inhibition (Kaila 1994). 
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2.3 Regulation of KCC2 function 
 
A characteristic feature of GABAAR-mediated signaling is that it can be 
qualitatively regulated through short- and long-term changes in the transmembrane anion 
gradients, namely those of Cl- and HCO3- (Kaila 1994; Blaesse et al. 2009). This property 
of GABAergic signaling has been dubbed “ionic plasticity”. In contrast to short-term 
ionic-plasticity, which is based on transient activity-dependent GABAAR-mediated anion 
shifts, long-term plasticity arises from changes in expression patterns and kinetic 
regulation of the molecular mechanisms responsible for the maintenance of 
transmembrane anion gradients (Rivera et al. 2005).  
Changes in the capacity of a presynaptic input to influence a postsynaptic output 
are thought to be important in learning, memory formation, neural development and 
pathological states of the CNS. GABAergic synaptic inhibition plays a critical role in 
regulating long-term potentiation (LTP) of glutamatergic synaptic transmission and 
circuit output (Gustafsson and Wigström 1988). The synaptic strength or efficacy of an 
inhibitory GABAergic synapse is dependent on both the density of GABAARs in the 
post-synaptic membrane (Nusser et al. 1998) and on the efficacy of KCC2 function in 
generating the driving force for GABAAR-mediated outward currents carried by Cl-. The 
polarity of GABAAR-mediated synaptic currents, i.e. whether the activation of 
GABAARs results in hyper- or depolarization of the post-synaptic membrane, depends on 
the relative membrane levels of functional KCC2 and NKCC1 (Khirug et al. 2008). The 
steady-state expression level of membrane-active CCCs may thus play a critical role in 
modulating the synaptic input-output relationships. In this context, the high turnover rate 
of membrane-bound KCC2, which will be discussed in detail below, points to changes in 
KCC2 expression as a possible novel mechanism in the control of neuronal plasticity via 
changes in the efficacy of inhibition (Rivera et al. 2004). 
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Figure 1. Schematic representation of the life cycle of a plasmalemmal ion transporter. Ion 
transporters, like other membrane proteins, are regulated at multiple levels (1-7) in a neuron, for details see 
text. From Gamba et al. 2009 
 
Ion transporter function is influenced by multiple regulatory mechanisms in the 
cell. At the transcriptional/translational levels (1-2, Fig. 1), the spatiotemporal tissue and 
cell-type specificity of synthesis of the transporter proteins is determined, followed by the 
post-translational level (3-6, Fig. 1), where the activity of the synthesized transporter 
protein is controlled by means of reversible events, such as (de)phosphorylation. 
Ultimately, the rate of protein degradation (7, Fig 1) delimits the minimum size of the 
membrane transporter pool of the cell. Additionally and less obviously, because 
cotransport is driven by the electrochemical gradients of the substrate ions, the efficacy of 
net transmembrane Cl- cotransport by KCC2 is also, in addition to the abovementioned 
regulatory processes (1-7, Fig. 1), influenced by thermodynamic forces. 
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2.3.1 Thermodynamics of KCC2 function 
 
Under physiological conditions, in a cell with an anion permeability, such as the 
one provided by GABAARs, but no active chloride transport, Cl- ions will distribute 
passively across the cell membrane following the Em of the cell. Since the inside of the 
cell is at a negative potential compared to the outside (typical values for a central neuron 
range from -50 to -90 mV), an electrical potential difference will drive negatively 
charged Cl- ions out of the cell against an inwardly directed Cl- concentration gradient 
(more precisely a chemical potential gradient). The sum of the electrical and chemical 
potential gradients, the electrochemical potential gradient of Cl- (∆µCl), is the driving 
force for Cl- ion flux:  
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RT )1(ln −+=∆ −
−
µ ,              (Eq. 1) 
where R is the ideal gas constant, T is the absolute temperature, [Cl-]i/[Cl-]o is the Cl- 
transmembrane concentration gradient and F is the Faraday constant. When the force 
generated by the chemical potential difference (1st term in Eq. 1) and the force generated 
by the electrical potential difference (2nd term in Eq. 1) are equal and opposite, Cl- ions 
are subject to no net driving force (∆µCl = 0) and a thermodynamic equilibrium is reached 
where no net Cl- flux across the membrane takes place:  
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The above equation is the Nernst equation for Cl- (Nernst 1888), which defines the 
transmembrane potential difference arising from a known transmembrane ionic 
concentration gradient at electrochemical equilibrium. Under conditions of no “apparent” 
active Cl- regulation, the Nernstian equilibrium potential for Cl- (ECl) is equal to Em. It is 
important to note here that condition ECl = Em does not rule out active Cl- cotransport. 
Because the cellular [Cl-]i is determined by the relative contribution of both the resting 
conductance and the active transport machinery, the contribution of an active Cl- 
loading/extruding component may be veiled when paralleled with a relatively large Cl- 
 11
conductance (Kaila et al. 1989; Alvarez-Leefmans and Delpire 2009). From the Nernst 
equation, it follows that under equilibrium conditions in total absence of active transport 
or in the presence of a relatively weak active transport component, [Cl-]i will change 
passively with Em: 
 
      [ ] [ ]
RT
FE
ClCl moi exp
−− = .                                  (Eq. 2.1) 
In most cells, including neurons, ECl and [Cl-]i are maintained at a different level 
than what is predicted by equations 2 and 2.1, suggesting that in these cells, active Cl- 
transport is sufficient enough to maintain Cl- out of thermodynamic equilibrium (Kaila 
1994). Neuronal [Cl-]i is maintained at a much lower level than is dictated by passive 
distribution via the action of KCC2, which utilizes the outwardly directed Na-K ATPase-
maintained electrochemical potential gradient of K+ to extrude Cl- in a 1:1 stoichiometry. 
The driving force (∆µK,Cl) for KCC2-mediated cotransport is determined by the sum of 
the electrochemical potential differences of K+ and Cl- (∆µK + ∆µCl): 
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Net extrusion of Cl- will take place until the transporter reaches thermodynamic 
equilibrium, a situation where ion fluxes mediated by KCC2 do take place, but the net 
effluxes and influxes of both K+ and Cl- are equal (Blaesse et al. 2009). KCC2-mediated 
transport may proceed in both directions as determined by the electrochemical driving 
forces of K+ and Cl- across the membrane. Under physiological ionic conditions transport 
is outward and proceeds towards equilibrium, where the net free energy change equals 
zero, which for the 1:1 substrate stoichiometry utilized by KCC2 corresponds to EK = ECl 
(Payne et al. 2003). Assuming that the system is in thermodynamic equilibrium, i.e. 
∆µK,Cl = 0, a simplification of equation 3 yields a definition of equilibrium for K-Cl 
cotransport: 
 
[ ] [ ] [ ] [ ]iioo KClKCl +−+− = .                       (Eq. 3.1) 
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The above equation demonstrates that KCC2 mediated cotransport is driven by the 
chemical potential differences of the substrate ions, K+ and Cl-. It also shows that an 
increase in [Cl-]i enhances net Cl- extrusion by KCC2 (Payne 1997). The presence of a 
strong thermodynamic driving force of substrate ions does not guarantee the activation of 
an ion transporter (Blaesse et al. 2009): no transporter may be present in the membrane at 
all or it may reside in a state that is incapable of ion transport. To better illustrate this 
state, an analogy with a closed ion channel is apt here: despite a large driving force that 
may exist across an ion channel, no charge movement across the membrane will take 
place if the channel resides in a closed state impermeable to ions. Similarly, a 
cotransporter will not move ions across the membrane if it resides in a functionally 
inactive state, despite the presence of large driving forces favoring net cotransport. Thus, 
although driving force dynamics play a role in regulation of KCC2-mediated cotransport, 
the number of ions transported per unit time is not only dependent on the digression of K+ 
and Cl- transmembrane gradients from thermodynamic equilibrium, but first of all on the 
degree of kinetic activation of the transporter, e.g. via phosphorylational mechanisms 
(Kaila 1994; Payne et al. 2003; Blaesse et al. 2009). 
  
2.3.2 Post-translational regulation of KCC2 function 
 
Important regulatory mechanisms of KCC2 function at the post-translational level 
comprise trafficking of the transporter molecule to the plasma membrane (4, Fig. 1), 
insertion of it into the membrane (4, Fig. 1), modulation of the intrinsic ion transport 
turnover rates of membrane-bound transporter molecules (5, Fig. 1) and the retrieval of 
the transporter from the membrane for recycling or degradation (6 and 7, respectively, 
Fig. 1) (Lee et al. 2007; Blaesse et al. 2009; Gamba et al. 2009).  
The neuron-specific KCC isoform was first cloned by Payne and co-workers 
(Payne et al. 1996), mapping possible targets for kinetic modulation of the cotransporter. 
Several protein kinase C (PKC) consensus phosphorylation sites were found to be located 
within the hydrophilic intracellular domains, as well as one consensus tyrosine protein 
kinase (PTK) phosphorylation site located in the large C-terminus, suggesting 
kinase/phosphatase-mediated regulation of KCC2 activity. It is of interest to note here 
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that the abundance of KCC2 protein in a neuron does not necessarily stipulate functional 
activity of the cotransporter. For example, the immature neurons in the auditory 
brainstem express KCC2 at a high level, yet the transporter is initially functionally 
inactive (Blaesse et al. 2006). In addition, inactive KCC2 can be activated rapidly using 
the broad-spectrum kinase inhibitor staurosporine in primary cortical cultures during the 
first days in vitro, although not in slice preparations (Khirug et al. 2005). A study by 
Kelsch et al. (2001) demonstrated that KCC2 activity in cultured hippocampal neurons 
required PTK activity, with a notably rapid time-course of KCC2 functional deactivation 
within minutes of tyrosine kinase inhibitor application. Furthermore, the co-application of  
c-Src, a member of the Src family of kinases, with insulin or insulin-like growth factor 
resulted in reactivation of KCC2 in 10 minutes, suggesting the involvement of Src kinase 
cascades in fast regulation of functional KCC2. 
It is worth noting here that most of the published data regarding kinetic and 
allosteric regulation of KCC2 do not explicitly indicate whether changes in the efficacy 
of KCC2-mediated cotransport are due to changes in the number of plasmalemmal 
transporters or due to the changes in their inherent transport rates, or both. Nevertheless, 
a recent paper by Lee et al. (2007) demonstrated that KCC2 membrane surface and 
functional expression can be both affected by PKC phosphorylation. Activation of PKC 
induced a rapid decrease in the rate of internalization of the cotransporter from the 
membrane, increasing cell surface expression levels of KCC2 by 200 % in a mere 10 
minutes, as measured using a biotinylation assay. Concurrently, the activity of KCC2, 
measured by a 86Rb+ flux assay, was comparably enhanced (Lee et al. 2007). These 
findings support the idea of rigorous functional regulation of KCC2 at the post-
translational level via phosphorylation-controlled membrane trafficking.  
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2.3.3 Regulation of KCC2 function at the translational level 
 
The overall turnover of KCC2 protein in the plasma membrane is apparently very 
short, measured in terms of tens of minutes (Rivera et al. 2004; Ouardouz and Sastry 
2005; Lee et al. 2007). The short membrane half-life of the cotransporter has been 
proposed to arise as a result of rapid genomically regulated turnover of KCC2 protein that 
is based on continuous kinetic modulation of KCC2 mRNA*, with protein levels of 
KCC2 quickly following its mRNA changes (Rivera et al. 2004; Uvarov et al. 2006; 
Yang et al. 2009).  
If levels of membrane-located KCC2 were to faithfully follow mRNA levels, the 
existing total KCC2 protein pool of the cell must be constantly subject to extremely 
efficient protein degradation. This suggests that under physiological conditions, 
maintenance of the plasmalemmal KCC2 is a balanced steady-state of de novo synthesis 
and degradation. Consequently, the experimental prevention of mRNA translation to 
KCC2 protein should lead to downregulation of KCC2 function with a time constant 
similar to that of the total KCC2 protein pool. Downregulation of KCC2 protein and 
function as a result of specific inhibition of KCC2 protein expression, using antisense 
oligonucleotides, has been demonstrated (Rivera et al. 1999). In this study, KCC2 total 
protein level was shown to dramatically decrease by the 8th hour after specific inhibition 
of synthesis, but unfortunately preventing mRNA translation using antisense 
oligonucleotides requires long incubation times for the translation block to reach  
significant levels, due to poor uptake into cells and degradation of oligonucleotides inside 
the cell (Keller et al. 2000),  thus precluding conclusions regarding the early degradation 
time course. 
Intriguingly, a study by Karnani (2008), which addressed the early (0-4 hours) 
effect of protein synthesis inhibition on KCC2 protein levels and function, demonstrated 
no change in total KCC2 protein levels yet a moderately-rapid downregulation of KCC2 
function, in the presence of the protein synthesis inhibitor emetine, with an estimated 
                                                 
* Very little is known about the transcriptional regulatory mechanisms concerning expression of KCC2. Promisingly, 
analysis of the KCC2 gene has identified several potential transcription factor binding sites in the KCC2 promoter 
region, including the transcription factor Egr4, which has been shown to have an effect on KCC2 transcription in 
cultured neurons (Uvarov et al. 2006). 
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half-life of 2.7 hours. Such inconsistency in stability of total protein levels versus 
function, observed in the Karnani study, can be explained e.g. by postulating two 
differentially regulated KCC2 pools with distinct half-lives. Namely, a large cytosolic 
pool with a moderate-to-long half-life, in the range of several hours, and a second smaller 
membrane-associated pool that is not replenished from the larger cytosolic pool, with a 
faster half-life. Here, the smaller plasmalemmal functional KCC2 could represent such a 
small fraction of the total KCC2 pool that its rapid degradation during arrest of protein 
synthesis can not be detected in immunoblot of total KCC2 (Karnani 2008). However, the 
second protein synthesis inhibitor used in the above study, anisomysin, did not reproduce 
the downregulating effect of emetine on KCC2 function. The discrepant result between 
the two protein synthesis inhibitors in the Karnani study was attributed to an unspecific 
post-translational activating effect on KCC2 function by anisomysin, based on the fact 
that under simultaneous application of both inhibitors, anisomysin prevented the emetine-
induced downregulation of KCC2 function. However, such an approach does not exclude 
the possibility that the effect on KCC2 function by emetine is also unrelated to protein 
synthesis inhibition, but it rather demonstrates that the unspecific effect by anisomysin is 
dominant over the one putatively posed by emetine. The results and methodology of the 
2008 Karnani study will be discussed in more detail later on, as this study and the present 
one are related in their topic and methodological approach.  
A rapid protein turnover of KCC2 (cf. Rivera et al. 2004) suggests that the 
efficacy of GABAAR-mediated signaling could be rapidly influenced, under both 
physiological and pathophysiological conditions, by factors regulating KCC2 gene 
expression. Interestingly, the elevation in neuronal [Cl-]i and depolarizing action of 
GABAARs that occur after trauma and epileptiform activity have been proposed to result 
as a consequence of post-traumatic reduction in KCC2 expression (Rivera et al. 2004; 
Bonislawski et al. 2007; Huberfeld et al. 2007). Dramatic loss of up to 80 % of KCC2 
protein has been observed after sustained interictal-like activity induced in hippocampal 
slices in the absence of Mg2+ (Thomas-Crusells et al. 2000; Rivera et al. 2004), 
glutamate-induced excitotoxicity (Chung and Payne 2001) and in a kindling model of 
epilepsy (Rivera et al. 2002).  
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Because the steady state level of any protein in a cell is a ratio of the rate of 
synthesis and the rate of degradation, it is difficult to discern whether rapid 
downregulation of KCC2 protein levels and function and the consequent depolarizing 
shift in GABAergic signaling reflect decreased protein synthesis, increased degradation 
or both. It remains largely unresolved whether pathological conditions can influence 
KCC2 protein level via modulating its native protein synthesis or degradation rates or 
both and thus confer KCC2 a differential half-life under post-traumatic versus 
physiological conditions. Since the action of translation inhibitors precludes synthesis of 
new protein, they can be used as tools to assess to which extent trauma-induced 
downregulation of KCC2 can be attributed to diminished de novo protein synthesis. 
In the present study, two protein synthesis inhibitors with a similar mode of action 
were used in order to reveal any unspecific effects the compounds might pose on the 
system under study. The two compounds in this study, emetine, a proemetic alkaloid, 
derived from the ipecac root, and cycloheximide (CHX), an antibiotic of bacterial origin 
share both structural similarity as well as analogy in inhibitory mode and site of action on 
the mammalian translational machinery. Both emetine and CHX inhibit the aminoacyl-
tRNA transfer reaction, preventing the peptide elongation phase during protein 
biosynthesis (Grollman 1966). CHX differs from emetine with respect to reversibility of 
its effect on protein synthesis; protein synthesis activity can be restored in CHX-treated 
cells by removal of the inhibitor from the surrounding medium (Grollman 1966, 1968). In 
contrast, the effect of emetine is irreversible; as a consequence, protein synthesis remains 
arrested also after removal of this inhibitor from the surrounding medium (Grollman 
1968; Stanton and Sarvey 1984). Control experiments indicating complete blockade of 
protein synthesis in acute hippocampal slices have been reported for both emetine 
(Bradshaw et al. 2003; Fonseca et al. 2006; Karnani 2008) and CHX (Stanton and Sarvey 
1984; Kang and Schuman 1996; F. Ahmad, unpublished) at the concentrations used in the 
present study.     
In summary, the reported high turnover rate of KCC2 protein under both 
physiological and pathophysiological conditions (Rivera et al. 2004) should permit the 
modulation of neuronal [Cl-]i to take place via changes at the level of KCC2 expression. 
Consequently, it should also permit the experimental use of translation inhibiting or 
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degradation enhancing drugs, as tools for rapid modulation of KCC2 function, alongside 
drugs modulating protein phosphorylation states already in use for rapid modulation of 
KCC2 function at the post-translational regulatory level (e.g. Kelsch et al. 2001; Khirug 
et al. 2005; Lee et al. 2007).   
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3. Aims of the study 
 
The K-Cl cotransporter KCC2 is a key molecule in neuronal chloride homeostasis 
and has a major impact on GABAergic signaling. KCC2 is modulated via short-term and 
long-term changes at the level of transcription, translation, post-translational 
modifications, and trafficking. Recent work suggests that a part of total KCC2 protein has 
a relatively fast turnover under controlled i.e. non-pathological conditions, with estimated 
half-lives ranging from ~15 min up to 2.7 hrs (Rivera et al. 2004, Karnani 2008). 
Validation of these estimates could have implications for mechanisms of neuronal 
development, plasticity and disease that can be rapidly regulated via genomic 
modulations of KCC2 function. 
 
The aims of this Master’s thesis were as follows: 
 
By experimentally preventing neuronal mRNA translation under controlled conditions 
 
1. To investigate the immediate (0-4 hours) degradation time-course of the 
functional KCC2 in CA1 pyramidal neurons. 
2. To examine the applicability of protein synthesis inhibitors as a method for 
modulation of KCC2 function. 
3. To compare the effects of different protein synthesis inhibitors on KCC2 function. 
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4. Materials and methods 
 
4.1 Preparation and maintenance of hippocampal slices 
 
The hippocampal formation of the rat (Rattus norvegicus) is anatomically and 
physiologically one of the most well-defined brain preparations, serving as a convenient 
model for cerebral structure and function. In the present study, the rat hippocampus was 
chosen as the experimental preparation because of its well characterized age-related 
expression pattern of functional KCC2. In the newborn rat pup, KCC2 expression is very 
low, but increases and plateaus by the end of the second postnatal week (Rivera et al. 
1999). This transcriptional upregulation is paralleled by a concurrent increase in KCC2 
function, which also hits a plateau by postnatal day 14-15 (Khirug et al. 2005). Thus, the 
stable baseline activity of KCC2 under normal conditions in the hippocampi of rats aged 
15 days and older provides a good model for assessing experimentally-induced changes 
in function of KCC2.    
Briefly, acute 400 µm coronal hippocampal slices were prepared from postnatal 
day 15 and 16 male Wistar rats using methods approved by the University of Helsinki 
Animal Care and Use Committee. Prior to decapitation, anesthesia was induced using 
halothane (Sigma, Germany). Brains were quickly removed and immersed into an ice-
cold (~3 °C) sectioning solution, containing (in mM): 87 NaCl, 2.5 KCl, 0.5 CaCl2, 25 
NaHCO3, 1.25 NaH2PO4, 7 MgSO4, 75 sucrose and 25 D-glucose, equilibrated with 
carbogen (95% O2 and 5% CO2), yielding a pH of 7.4 at 32 °C. Tissue containing the 
intact hippocampi was dissected and fixed with cyanoacrylate glue (Henkel, Germany) 
onto the stage of a Vibratome 3000 Plus (Vibratome, USA) for slicing while immersed in 
cooled (~3 °C) sectioning solution. Slices were used within 4 h, after a 1 h recovery 
period at 36 °C in recovery solution containing (in mM): 124 NaCl, 3 KCl, 2 CaCl2, 25 
NaHCO3, 1.1 NaH2PO4, 2 MgSO4, 6 MgCl2 and 10 D-glucose, continuously bubbled 
with carbogen. After the recovery period, the slices were maintained at 32 °C in the 
carbogen-bubbled recovery solution until they were placed in a submerged-type chamber 
(volume ~1 ml) for recording. Slices were anchored with a stainless steel Lycra-threaded 
harp (Warner Instruments, USA) and perfused with a standard extracellular solution 
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(flow rate 1 ml/min), which contained (in mM) 124 NaCl, 3 KCl, 2 CaCl2, 25 NaHCO3, 
1.1 NaH2PO4, 2 MgSO4, and 10 D-glucose, bubbled with carbogen (pH 7.4 at 32 °C).  
The following drugs were added to the standard extracellular solution in which all 
electrophysiological measurements were performed: action potentials were blocked with 
0.5 µM TTX (Tocris, UK) and AMPA-type receptors with 10 µM CNQX (Sigma, 
Germany), GABAB receptors were blocked with 1 µM CGP 55845 (Tocris, UK) and 
NKCC1 was blocked with 10 µM bumetanide (Sigma, Germany) (Russell 2000). To 
acutely inhibit KCC2 activity, 1 mM furosemide (Sigma, Germany) was used in addition 
to the aforementioned drugs (Payne 1997). Slices were exposed to furosemide for at least 
30 minutes before measurements were carried out.   
In the protein synthesis inhibitor experiments, hippocampal slices were exposed, 
immediately after the end of the 1 h recovery period at 36 °C, to 100 µM cycloheximide 
(CHX) or emetine dihydrochloride (Sigma, Germany) in the recovery solution. CHX was 
present throughout the experimental procedure also in the standard extracellular solution. 
In experiments with emetine, slices were incubated in emetine for 30 minutes in the 
recovery solution, after which they were transferred and maintained in emetine-free 
recovery solution up until the point of transfer to emetine-free standard solution for 
electrophysiological recording. In part of the experiments, as indicated, emetine was 
maintained in the extracellular solution throughout the experimental procedure. 
 
4.2 Whole-cell somato-dendritic EGABA gradient measurements 
 
Previous work has shown that plasmalemmal ion transporters are able to maintain 
not only transmembrane [Cl-] gradients, but also intracellular [Cl-] gradients along the 
dendrites and axons of central neurons. These gradients emerge from the differential 
distribution of Na-K- and K-coupled Cl- cotransport mechanisms, mediated by NKCC1 
and KCC2, respectively, in the axonal, somatic and dendritic “compartments” of central 
neurons. NKCC1 and KCC2 are often coexpressed in mature neurons, and spatially 
distinct expression patterns can result in steady-state intraneuronal chloride gradients and 
compartmentalization of EGABA within an individual neuron (Szabadics et al. 2006; 
Khirug et al. 2008; Blaesse et al. 2009). 
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 It appears that, for instance, in the mature dentate granule cells, NKCC1 is 
responsible for the depolarizing EGABA values observed in the axon initial segment, where 
expression of KCC2 is indetectable (Szabadics et al. 2006). This observation effectively 
dismisses the idea of a single EGABA value per neuron, and suggests a dynamic range of 
input-specific neuronal EGABA values in the same cell, based on the local relative 
efficiency of the two Cl- cotransporters (Khirug et al. 2008; Blaesse et al. 2009). 
Consequently, measuring the somatic EGABA value bares no information about other 
cellular compartments, where Cl- regulation may be drastically different. The steady-state 
EGABA gradients can be quite large, e.g. in cortical principal neurons, the axo-somato-
dendritic EGABA gradient reaches a value up to 15–20 mV (Khirug et al 2008). Most 
importantly, measuring the steady-state EGABA in a resting neuron can at best verify the 
presence of Cl- extrusion, but bares no information on its efficacy. Provided that net Cl- 
influx into a cell i.e. Cl- load is small, even an inefficient cellular Cl- extrusion machinery 
will be able to maintain a hyperpolarizing EGABA (Blaesse et al. 2009). The unrelialability 
of EGABA as an inidicator of neuronal Cl- extrusion capacity was demonstrated in a study 
on chronically injured epileptogenic cortex, which showed that a significant decrease in 
KCC2 function was not seen as a change in steady-state EGABA (Jin et al. 2005). 
In order to quantitatively assess the efficacy of Cl- extrusion, a defined Cl- load 
must be imposed on a cell. The capability of the cell to maintain the [Cl-]i then provides a 
valid estimate of the efficacy of extrusion (Jarolimek et al. 1999; Rivera et al. 2004; 
Khirug et al. 2005).  
Plasmalemmal ion transporters are able to maintain intracellular [Cl-]i gradients 
also during a somatic Cl- load under whole-cell conditions (Jarolimek et al. 1999; Khirug 
et al. 2005 and 2008; Blaesse et al. 2006; Li et al. 2007). In the whole-cell configuration 
of the patch clamp technique (Hamill et al. 1981), where, in addition to forming a high 
resistance gigaohm (GΩ) seal between the glass micropipette and a patch of cell 
membrane using gentle suction, the sealed patch of membrane is ruptured by additional 
application of suction and direct access to the inside of the cell is gained. Since the 
volume of the pipette is much greater than that of the cell, the cell interior is dialyzed 
with the contents of the electrode (Marty and Neher 1983).  
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In the present study, in order to assess KCC2 function quantitatively, the somato-
dendritic EGABA gradient (∆EGABA = EGABA(soma) - EGABA(dendrite)), a measure of KCC2 
functionality, was determined. An artificial defined Cl- load imposed via a patch pipette 
clamps the somatic [Cl-] to that of the pipette ([Cl-]pip). As a result of net dendritic Cl- 
extrusion by KCC2, a declining somato-dendritic Cl- concentration gradient is formed 
from the soma along the dendrite (Fig. 2B).  
 
 
Figure 2. The experimental conditions for quantified assessment of KCC2 function A Schematic 
diagram of the experimental setup used for local photolysis of caged GABA, confocal microscopy, and 
somato-dendritic EGABA gradient measurements. From Khiroug et al. 2003. B Schematic diagram of the 
somatic Cl- loading assay used to quantify KCC2 function. The somato-dendritic EGABA gradient, measure 
of KCC2 functionality, was measured. Briefly, an artificial defined Cl- load imposed via a patch pipette 
clamps the somatic [Cl-] to that of the pipette ([Cl-]pip). As a result of net dendritic Cl
- extrusion by KCC2, a 
declining somato-dendritic Cl- concentration gradient is formed from the soma along the dendrite (indicated 
in B as lightening of gray from the soma to the distal dendritic parts). Focal photolytic release of caged 
GABA was used to determine the local EGABA (and thus the local [Cl
-]i as calculated from the GHK voltage 
equation) at the soma (EGABA(soma)) and the dendrite (EGABA(dendrite)). If EGABA(dendrite)<EGABA(soma), an effective 
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Cl- extrusion mechanism is present. Modified from Blaesse et al. 2006. C A confocal micrograph of a 
fluorescent CA1 pyramidal neuron loaded with Alexa Fluor 488 through the patch pipette. Pyramidal 
neurons were visualized in order to identify a distance of 50 µm from the soma along the apical dendrite, 
where the EGABA(dendrite) was measured. A spot of UV light was positioned consecutively at the somatic and 
the dendritic location for local GABA uncaging in order to evoke GABAAR-mediated currents. The 
potential at which these currents reverse in polarity defines EGABA. Circles indicate the approximate size 
and locations of the UV spot used for uncaging. In B and C flashes indicate sites of GABA uncaging.  
 
Focal photolytic release of caged GABA (Fig. 2C) was used to determine the local EGABA 
(and thus the local [Cl-]i as calculated from the GHK equation) at the soma (EGABA(soma)) 
and the apical dendrite (EGABA(dendrite)) 50 µm distance away from the soma. If 
EGABA(dendrite)<EGABA(soma), an effective furosemide sensitive Cl- extrusion mechanism is 
present (Jarolimek et al. 1999). The magnitude of this gradient along a distance from the 
load source directly depends on the local dendritic Cl- extrusion capacity of the cell 
(Blaesse et al. 2009).  
 
4.2.1 Electrophysiology  
 
Somatic patch-clamp recordings were carried out at 32 °C in the whole-cell 
voltage-clamp configuration using an EPC 10 patch-clamp amplifier (HEKA Elektronik, 
Germany) on CA1 pyramidal neurons. Patch pipettes were fabricated from borosilicate 
glass (Harvard Apparatus, UK), and their resistances ranged from 4.0 to 6.5 MΩ. Seal 
resistances were 2-10 GΩ and pipette capacitance was compensated before breaking the 
cell membrane (Marty and Neher 1983). The membrane potential values were corrected 
offline for the agar salt bridge-measured liquid junction potential of 10 mV (Barry and 
Diamond 1970).  
To correctly estimate dendritic Cl- extrusion capacity using the somatic loading 
technique, the artificial Cl- load chosen should preferably be close to the concentration 
that clamps the somatic [Cl-] ([Cl-]soma) to that of the patch pipette ([Cl-]pipette). If the 
chosen Cl- load is subsaturating, part of the Cl- extrusion machinery will remain “idle”, 
resulting in an underestimation of extrusion capacity. Thus, too small a load will produce 
a false negative error concerning the high Cl- extrusion capacity, i.e. the true capacity is 
actually larger than what is given by the measured parameter indicating apparent 
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extrusion capacity. The patch pipette intracellular solution contained (in mM): 18 KCl, 
111 K-gluconate, 0.5 CaCl2, 2 NaOH, 10 D-glucose, 10 HEPES, and 2 Mg-ATP,             
5 BAPTA (pH 7.3 was adjusted with KOH), yielding a [Cl-]pipette of 19 mM and an EGABA 
of -48 mV (Khirug et al. 2005). The Cl- concentration of 19 mM in the patch pipette was 
calculated on the basis of the GHK voltage equation (Eq. 3) in order to clamp the somatic 
EGABA at approximately -48 mV. Control measurements of the somatic EGABA with         
19 mM [Cl-] in the pipette resulted in an average of -49 ± 0.53 mV (n=26), which is 
consistent with the theoretically expected value of -48 mV, demonstrating successful Cl- 
loading of the soma and clamping of [Cl-]soma to [Cl-]pipette under the present conditions. 
Similar somatic EGABA values to the ones observed here, have been reported previously 
with the present [Cl-]pipette in hippocampal CA1 pyramidal neurons in acute slices and in 
hippocampal neuronal cultures (Khirug et al. 2005) as well in neurons of the lateral 
superior olive in the brainstem (Blaesse et al. 2006).  
CA1 pyramidal neurons were voltage clamped at a holding potential (VH) of         
-50 mV. A holding potential deviant from the resting membrane potential but close to the 
calculated EGABA was chosen in order to avoid measuring an EGABA influenced by a large 
outwardly directed driving force for Cl- (Akaike et al. 1987), minimizing the leak Cl- 
conductance as the driving force (DF) for net transmembrane Cl- flux is close to zero           
(DF = VH - EGABA). The reversal potential of GABAergic currents (IGABA = 0) was 
determined from the current–voltage (I–V) relation obtained by sequentially clamping the 
cell membrane at six different holding potentials with a 5 mV increment and a 10 s 
interval between subsequent holding levels. The 4 peak IGABA values with the most 
voltage-linearity around the zero-current potential where used to plot the I-V relation. 
Step voltages lasted 200 ms and ranged from -65 mV to -35 mV and -70 mV to -40 mV 
for somatic and dendritic EGABA measurements, respectively. Caged GABA was 
photolyzed to evoke GABAAR-mediated currents 50 ms after the start of each voltage 
step, as described below. 
Each cell was recorded only once and measurements at both sites were carried out 
twice for each cell. A single recording lasted approximately 15 min: after going to whole-
cell mode the somato-dendritic Cl- gradient was allowed to stabilize for 5 min followed 
by determination of EGABA(soma), then EGABA(dendrite) with a 2 min interval. After 2 min 
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these measurements were repeated for increased accuracy. The order of measurement of 
the somatic and dendritic EGABA had no effect on the measured ∆EGABA gradient (data not 
shown). 
Only cells with a resting membrane potential more negative than -50 mV were 
included in the analysis. It was observed that a low input/series resistance ratio correlates 
with drifts in the measured ∆EGABA gradients (data not shown), probably due to poor 
somatic Cl- loading of larger volume cells, resulting from clogging of the pipette tip with 
cell membrane debris. Thus, only cells with input resistance minimum 10x the series 
resistance, were accepted for analysis. 
Statistical analysis and curve fitting were performed using Origin (Microcal 
Software, USA) and Sigmaplot 10 (Systat, USA) software. Statistical significance was 
assessed using the unpaired Student’s t-test. Differences with p < 0.01 were considered 
significant. All averaged data are presented as mean ± standard error of the mean. 
 
4.2.2 Visual identification of apical dendrites and local photolysis of caged GABA 
 
In order to visualize the dendrites and accurately measure the distance from the 
soma, a fluorescent indicator (Alexa Fluor 488, 100 µM; Invitrogen, USA) was dialyzed 
via the patch pipette, and dendrites were traced using a Radiance 2100 confocal 
microscope (Bio-Rad, UK) (Fig. 2C). Only cells with an apical dendrite clearly visible in 
the XY-plane of stratum radiatum were recorded from, so as to avoid false estimates of 
the standard 50 µm somato-dendritic span. Alexa Fluor 488 fluorescence was excited at 
488 nm and recorded using a 520 nm long-pass filter. 
After visual identification of the correct location for uncaging, GABA was 
photolyzed from α-Carboxy-2-nitrobenzyl (CNB)-caged GABA compound (Invitrogen, 
Germany) using local uncaging, as described by Khirug et al. (2005). Briefly, the caged 
compound was dissolved in a 12 mM stock in physiological solution containing (in mM): 
127 NaCl, 3 KCl, 2 CaCl2, 1.3 MgCl2, 20 HEPES, 10 D-glucose, pH 7.4. Before each 
experiment, a freshly thawed aliquot of the above stock was diluted to a final 
concentration of 2 mM of the caged GABA in the standard extracellular solution and 
delivered to the vicinity of the patch-clamped cell at a flow rate of 1-2 µl/min using an 
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UltraMicroPump II syringe pump (WPI, USA) and a syringe with a 100 µm inner tip 
diameter (Fig. 2A). For local photolysis of caged GABA, the 375 nm output of a 
continuous emission diode laser (Spectra Physics, USA) was delivered to the slice 
through an LUMPlanFl 60x water-immersion objective (Olympus, Japan) (Fig. 2A). An 
electronic shutter (AA Opto-Electronic, France) was used to set the duration of the laser 
pulse at 10-20 ms (Fig. 2A). The UV laser beam was focused to yield an uncaging spot of 
~10 µm in diameter (Khirug et al. 2005) either at the soma or at the apical dendrite at a 
distance of 50 µm from the soma (Figs. 2B and 2C). 
Control experiments were performed (data not shown; cf. Khirug et al. 2008) to 
verify that the laser flash evoked no responses in the absence of the CNB-caged GABA 
and that caged GABA, when added to the bath solution, did not induce any membrane 
current or changes in the input resistance. Furthermore, changing the intensity of the laser 
pulse within the range used in this study had no effect on the measured value of EGABA. 
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5. Results and discussion 
 
5.1 KCC2 function is maintained for hours in the absence of de novo translation 
 
Under steady-state conditions, the rate of protein synthesis equals the rate of 
protein degradation. Hence, the working hypothesis of the present study was that slice 
exposure to protein synthesis inhibitor will prevent the synthesis of new protein 
molecules, revealing the protein degradation rate as decay in KCC2 functionality, 
provided that protein degradation is preserved under the block of translation (Li et al. 
1998; Fonseca et al. 2006; P. Blaesse and B. Haas, unpublished observations). Thus, the 
fall in KCC2 expression should be paralleled by a decrease in the neuronal Cl- extrusion 
capacity.     
The functional half-life of KCC2 was studied by recording the somato-dendritic 
∆EGABA gradient of CA1 pyramidal neurons under arrested mRNA translation induced by 
protein synthesis inhibitors CHX and emetine. Given that under the present experimental 
conditions NKCC1 has been blocked with bumetanide (Payne et al. 2003; Khirug et al. 
2008), the furosemide sensitive part of the somato-dendritic ∆EGABA can be attributed to 
Cl- extrusion by KCC2 (Li et al. 2007; Khirug et al. 2010), which leads to a more 
negative dendritic EGABA relative to the clamped somatic one. 
A recent study with a similar approach to assessing the genomically regulated 
half-life of the functional membrane-associated KCC2, showed a marked emetine-
induced downregulation of KCC2 function, with an estimated half-life of 2.7 hours 
(Karnani 2008). Surprisingly, this study also showed that the total KCC2 pool does not 
decrease in parallel with impaired KCC2 function, leading Karnani to speculate about the 
existence of two distinct KCC2 pools, with differential turnover rates, to account for the 
observed discrepancy. Interestingly, the second protein synthesis inhibitor used in the 
Karnani study, anisomycin, did not confirm the emetine effect, which casts doubts on the 
genomic origin of the reported half-life of 2.7 hours for the functional pool. What turned 
out to be a crucial question regarding the present investigation was whether the 
lipophilicity (octanol/water partition coefficient: 2.58) of emetine and irreversibility of its 
binding somehow contributes to the downregulation of KCC2 function in an unspecific 
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manner that is unrelated to the inhibitory action of emetine on the neuronal translational 
machinery. In the 2008 study by Karnani, exposure of hippocampal slices to 100 µM 
emetine was maintained throughout the entire length of the experimental time-window of 
4 hours. Keeping in mind the lipophilicity and irreversibility of emetine (Grollman 1968; 
Stanton and Sarvey 1984), such approach makes the possibility for unspecific membrane-
action due to high lipophilicity a plausible source of possible unspecific drug effects by 
emetine (cf. Pan and Combs 2003). 
The present author set forth to test the hypothesis that the hours-on long emetine 
application itself and not arrest of protein synthesis per se, is the primary cause for the 
moderately rapid downregulation of KCC2 function reported by Karnani (2008). To this 
end, hippocampal slices were incubated in 100 µM emetine either for 30 minutes, after 
which they were transferred to emetine-free conditions, or alternatively their exposure to 
bath-applied emetine was continued until the end of the experiment i.e. up to 4 hours. A 
minimum incubation time period of 30 minutes was chosen based on a number of studies 
on the protein synthesis-dependent late-phase of LTP, which show that even an 
incubation this brief is sufficient to block late-phase LTP (e.g. Stanton and Sarvey 1984; 
Huang and Kandel 2006). ∆EGABA measurements from slices without application of any 
translation inhibitors, and thus with presumably a fully functioning proteosynthetic 
machinery, were performed at the 1st and the 4th hour experimental hour, to investigate 
the stability of KCC2 function under control conditions. Mean ∆EGABA values obtained at 
the 1st versus the 4th hour did not differ statistically (7.39 ± 0.38 mV/50 µm and            
7.68 ± 0.46 mV/50 µm, respectively; p = 0.668; Fig. 4D), providing a stable baseline, 
within the present experimental time window of 4 hours. ∆EGABA measurements from 
slices initially exposed to emetine for 30 minutes only showed no change in the level of 
KCC2 function after 4 hours, as compared to time-matched control slices (7.86 ± 0.68 
mV/50 µm; p = 0.823; Fig. 3D). Slices that were incubated for an additional 30 minutes, 
thus altogether for 1 hour and slices that were left in emetine until the very end of the 4th 
hour, both demonstrated a progressive and highly significant decrease in KCC2 function 
(5.53 ± 0.25 mV/50 µm; p = 0.000778 and 3.27 ± 0.29 mV/50 µm; p = 0.0000292, 
respectively, as compared to slices incubated for 30 minutes only; Fig. 3D). These data 
clearly show that downregulation of KCC2 function, in 100 µM emetine, is not a result of 
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inhibited protein synthesis, but rather an unspecific tissue accumulation-related effect of 
long emetine incubation. Because an emetine exposure of only 30 minutes did not lead to 
downregulation of ∆EGABA for the minimum of the experimental time period of 4 hours 
used herein, but this incubation time is sufficient to irreversibly block protein synthesis at 
the concentration used (Stanton and Sarvey 1984), the above data effectively dismiss the 
moderately rapid genomically regulated half-life for the functional membrane-located 
KCC2 of 2.7 hours proposed by Karnani (2008). 
 
Figure 3. KCC2 function, measured as somato-dendritic ∆EGABA, is suppressed in a manner that is 
directly dependent on the duration length of incubation of hippocampal slices in 100 µM emetine.   
A-C Sample EGABA recordings at the soma and at a distance of 50 µm in the apical dendrite. Uncaging flash 
indicated by horizontal bars. I-V curves, based on uncaging-induced GABAAR-mediated currents (IGABA) at 
different holding potentials (Vh; original traces shown as insets here and in subsequent illustrations), used 
to determine the somatic and dendritic EGABA values at the 4
th hour after a 30 minute-long emetine 
incubation (A), at the 1st (B) and at the 4th (C) hour of continuous emetine incubation. D Bars represent 
pooled data for recordings from individual cells during the 4th control hour, 4th hour of a 30 minute-long 
emetine incubation and during the 1st and the 4th hour of continuous emetine incubation, as indicated. The 
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mean values of ∆EGABA measurements from the 4
th hour from slices that were incubated in emetine for 30 
minutes only showed no difference from time-matched control slices (p = 0.449). In contrast, ∆EGABA 
measurements from the 4th hour from slices that were incubated in emetine for 1 hour demonstrated a 
highly significant decrease in KCC2 function (p = 0.000778) compared to mean ∆EGABA values measured at 
the 4th hour from slices originally incubated for only 30 minutes. Mean values from slices that were 
incubated in emetine until the very end of the 4th hour showed a dramatic additional decrease in ∆EGABA     
(p = 0.000029) compared to time-matched slices subjected to an incubation period of 30 minutes only. The 
values for n are shown in brackets. 
 
In order to exclude the possibility of lack of an effect on KCC2 function after 2.5 
hours by the short 30 minute emetine incubation due to “wearing-off” of the mRNA 
translation arrest, as well as to provide additional support for the proposed origin of the 
unspecific emetine-effect, hippocampal slices were incubated for 4 hours in the reversible 
protein synthesis inhibitor CHX, after which the level of KCC2 function was assessed. In 
strict accordance with the ∆EGABA measured at the 4th hour after the short emetine 
incubation, the mean ∆EGABA measured from cells exposed to CHX for 4 hours showed 
no statistically significant change in the level of KCC2 function from time-matched 
control values (8.25 ± 0.23 mV/50 µm; p = 0.449; Fig. 4D). The stability of KCC2 
function under both, the continuously present reversible CHX, and the irreversible 
emetine applied for 30 minutes, indicates that the lack of effect on KCC2 function by the 
short emetine application is a consequence of the fact that cessation of de novo protein 
synthesis has no effect on KCC2 function within the present experimental time window 
of 4 hours, rather than that of wearing-off of emetine-induced translation block. In sum, 
these experiments show that protein synthesis inhibition alone is not sufficient to rapidly 
downregulate KCC2 function. 
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Figure 4. KCC2 function, measured as somato-dendritic ∆EGABA, remains stable for a minimum of 4 
hours under cycloheximide- (CHX) or emetine-arrested mRNA translation. A-C Sample EGABA 
recordings at the soma and at a distance of 50 µm in the apical dendrite. Uncaging flash indicated by 
horizontal bars. I-V curves, based on uncaging-induced GABAAR-mediated currents (IGABA) at different 
holding potentials (Vh), used to determine the somatic and dendritic EGABA values during the 1
st and the 4th 
hour under control conditions (A and B, respectively) and during the 4th hour of arrested protein synthesis 
induced by CHX (C) and emetine (cf. Fig. 3A). D Bars represent pooled data for recordings from 
individual cells during the 1st or the 4th hour, as is individually indicated. The mean values of ∆EGABA 
demonstrated no significant change under control conditions between the 1st and the 4th hour (p = 0.668). 
Mean ∆EGABA values measured at the 4
th hour under both CHX- and emetine-inhibited protein synthesis 
were statistically not different from those observed under time-matched control values (p = 0.486 and         
p = 0.449, respectively). ∆EGABA values measured under emetine were obtained from slices subjected to 100 
µM emetine incubation of 30 minutes after which slices were maintained in emetine-free conditions. CHX 
∆EGABA values were obtained from slices incubated in 100 µM CHX throughout the entire length of the 
experiment. The values for n are shown in brackets. 
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5.2 Somato-dendritic EGABA gradients retain furosemide-sensitivity during 
inhibited protein synthesis 
 
 In order to confirm that the somato-dendritic EGABA gradients maintained in the 
presence of inhibited protein synthesis originate from and are dependent on KCC2-
mediated K-Cl cotransport, the furosemide-sensitivity of the recorded ∆EGABA under the 
present experimental conditions was assessed. Furosemide, a diuretic, blocks both 
NKCC1 and KCCs with an equal potency (Payne 1997), and it is often used at 100 µM or 
higher to inhibit KCC2 in experiments on neuronal cultures and slices (Blaesse et al. 
2009; Viitanen et al. 2010). Here, 1 mM furosemide was bath-applied for at least 30 min 
before measuring ∆EGABA. Furosemide application alone induced a highly significant 
decrease in ∆EGABA from the control value of 7.43 ± 0.25 mV/50 µm to                       
3.46 ± 0.47 mV/50 µm (p = 0.0000018; Fig. 5C). Furosemide also successfully reduced 
the ∆EGABA of CA1 pyramidal neurons exposed for 4 hours to 100 µM CHX to the 
furosemide-insensitive level, statistically not different from that observed under control 
furosemide levels (3.93 ± 0.66 mV/50 µm; p = 0.624; Fig 5C). These residual 
furosemide-insensitive gradients observed under both control conditions and during the 
4th hour of CHX incubation are comparable to ∆EGABA gradients previously reported for 
KCC2 knockouts (Li et al. 2007) and immature pyramidal neurons (Khirug et al. 2005), 
which lack KCC2 activity (Rivera et al. 1999), suggesting that the ∆EGABA gradients 
maintained in the presence of inhibited protein synthesis are indeed a product of KCC2-
mediated Cl- extrusion. 
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Figure 5. Furosemide sensitivity of somato-
dendritic ∆EGABA in the presence of cycloheximide 
(CHX). A-B Sample EGABA recordings at the soma 
and at a distance of 50 µm in the apical dendrite. 
Uncaging flash indicated by horizontal bars. I-V 
curves, based on uncaging-induced GABAAR-
mediated currents (IGABA) at different holding 
potentials (Vh), used to determine the somatic and 
dendritic EGABA values under bath application of 
furosemide   alone  (A)  and  furosemide   after   a  4 
hour  incubation in  CHX (B). C Bars represent pooled data for recordings from individual cells. Control 
and control + furosemide ∆EGABA values where measured at random time points during the 4 hour period 
and pooled. Bath application (>30min) of furosemide (1 mM) alone induced a highly significant 
downregulation of mean ∆EGABA from control values (p = 0.0000018). Somato-dendritic EGABA gradients 
remained furosemide-sensitive in the presence of CHX (100 µM) (p = 0.0000022, as compared to control 
∆EGABA values). The furosemide-sensitivity of ∆EGABA under CHX was not statistically different from 
furosemide-treated slices not exposed to CHX (p = 0.624). The values for n are shown in brackets.  
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6. Conclusions 
 
The main finding of this Master’s thesis was that de novo protein synthesis is not 
a requirement for maintaining KCC2 function for at least 4 hours at a level observed 
under physiological conditions in neurons with mature levels of KCC2 expression and 
function (Rivera et al. 1999; Khirug et al. 2005). This finding strongly argues against the 
idea of special rapid genomic regulation of the membrane-associated functional KCC2, 
and suggests that under physiological conditions the functional KCC2 protein does not 
have a shorter protein half-life than the total cytosolic KCC2 protein. 
Downregulation of KCC2 protein has been shown to take place shortly following 
traumatic brain injury (Chung and Payne 2009) and low levels of KCC2 can persist long-
term post brain trauma (Bonislawski et al. 2007). It is entirely possible that trauma-
induced downregulation of KCC2 reflects enhanced degradation of the cotransporter, for 
example by protease activation (Chung and Payne 2009). It is intuitively appealing to 
assume that trauma-induced loss of KCC2 protein expression in mature neurons involves 
both degradation of KCC2 protein and cessation of KCC2 gene expression. The results of 
this study clearly show that the latter plays a much smaller role than the former in 
downregulating KCC2 function, since the mere prevention of de novo translation did not 
lead to rapid loss of neuronal Cl- extrusion capacity. This finding indirectly highlights the 
importance of the involvement of the cellular protein degradation in the regulation of Cl- 
transport and consequently GABAergic responses, especially in the post-traumatic brain.  
One of the more technical aims of this thesis work was to examine the 
applicability of protein synthesis inhibitors as a method for rapid modulation of KCC2 
function. To the best of the knowledge of the present author, the literature does not 
identify any effects of cycloheximide unrelated to protein synthesis inhibition that can be 
directly linked to post-translational modulation of K-Cl cotransport, on the other hand, 
emetine has recently been identified as an activator of PP1 (type 1 serine/threonine 
protein phosphatase) (Boon-Unge et al. 2007), which at least in the red blood cells 
(RBCs) is a modulator of K-Cl cotransport (Jennings and Schulz 1991; Kaji and 
Tsukitani 1991; Bize et al. 1999; De Franceschi et al. 2006). The early findings that 
protein phosphatase inhibitor okadaic acid inhibits KCC activity in RBCs (Jennings and 
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Schulz 1991; Kaji and Tsukitani 1991) support the notion that PPs may play a regulatory 
role in KCC function. Elevated activity levels of PP1 (Bize et al. 1999) and its isoform 
PP1α (De Franceschi et al. 2006) in the erythrocyte membrane are associated with 
elevated levels of K-Cl cotransport in RBCs, most likely via action of Src family kinases 
(De Franceschi et al. 2006). Although increased PP1 activity clearly induces an 
upregulation of KCC function in RBCs, depending on the system, phosphorylation may 
result in increased or decreased activity of the target protein (Wera and Hemmings 1995); 
consequently, PP1 activation may impose a differential effect on KCC function in 
neurons. Thus, the present author proposes that emetine, at high intracellular 
concentrations (>100 µM) arising from unspecific effect during incubations longer than 
30 minutes, may result in loss of KCC2 function via post-translational mechanisms. 
Consequently long incubations at high concentrations should be avoided in experimental 
work utilizing emetine to avoid unspecific effects unrelated to protein synthesis 
inhibition. 
The observed stability of KCC2 function under arrested protein synthesis by the 
two protein synthesis inhibitors used in this study, precludes the use of translation 
inhibitors for immediate (<4 hours) prevention of KCC2-mediated Cl- extrusion, and thus 
their use as tools for rapid modulation of KCC2 function at the genomic level, alongside 
drugs modulating protein phosphorylation states (e.g. Kelsch et al. 2001; Khirug et al. 
2005; Lee et al. 2007). The results of this study do not exclude, but rather promote the 
importance of cellular protein degradation rates in rapid modulation of KCC2 protein 
levels and concomitantly function, e.g. in studies modeling the effects of brain trauma on 
the inhibitory system.     
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